Certolizumab pegol for induction of remission in Crohn's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Certolizumab Pegol for Induction of Remission in Crohn's Disease." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/439733/all/. Accessed 03 May 2024.
Certolizumab pegol for induction of remission in Crohn's disease. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/439733/all/. Accessed May 3, 2024.
Certolizumab pegol for induction of remission in Crohn's disease. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/439733/all/
Certolizumab Pegol for Induction of Remission in Crohn's Disease [Internet]. In: Cochrane Abstracts. [cited 2024 May 03]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/439733/all/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Certolizumab pegol for induction of remission in Crohn's disease
ID - 439733
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/439733/all/
DB - Evidence Central
DP - Unbound Medicine
ER -